Himanshu Reddy

Phase III, Randomized, Double-blind, Placebo controlled trial of Efficacy, Safety and Tolerability of Antiviral drug Umifenovir vs Standard care of therapy in non-severe COVID-19 patients

Ravishankar Ramachandran, Vivek Bhosale, Himanshu Reddy et al. · International Journal of Infectious Diseases · 2021 · 29 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9

Co-administration of AYUSH 64 as an adjunct to standard of care in mild and moderate COVID-19: A randomized, controlled, multicentric clinical trial

Arvind Chopra, Girish Tillu, Kuldeep Chuadhary et al. · PLoS ONE · 2023 · 25 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Hematological and serum biochemistry parameters as a prognostic indicator of severally ill versus mild Covid-19 patients: A study from tertiary hospital in North India

Deval Brajesh Dubey, Sridhar Mishra, Himanshu Reddy et al. · Clinical Epidemiology and Global Health · 2021 · 19 citations · Full text

Medicine, Hematology, Infectious Diseases +11

Coadministration of AYUSH 64 as an adjunct to Standard of Care in mild and moderate COVID-19: A randomised, controlled, multicentric clinical trial

Arvind Chopra, Girish Tillu, Kuldeep Chuadhary et al. · medRxiv · 2021 · 17 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9

Efficacy and safety of Tinospora cordifolia (Tc) as an add-on therapy in patients with type-2 diabetes

Saumya Mishra, Narsingh Verma, Sandeep Bhattacharya et al. · International Journal of Research in Medical Sciences · 2015 · 11 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17